Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.56 | 52 Week High | $19.62 | |||
| Open | $1.56 | 52 Week Low | $7.65 | |||
| Day High | $1.56 | P/E | N/A | |||
| Day Low | $1.56 | EPS | $-0.22 | |||
| Volume | 48 | |||||
